Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05245864 · ClinicalTrials.gov registry record · NA
Blood Flow Restriction Training in ACL Surgery
A NA study, sponsored by University of Arkansas.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05245864: Clinical Trial NA study, sponsored by University of Arkansas.
NCT05245864 is a NA study that was terminated before completion, run by University of Arkansas. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05245864, a NA study, was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This will be a randomized pilot study to determine the effectiveness of Personalized Blood Flow Restriction (PBFR) technique in conjunction with prescribed physical therapy (PT) in a cohort of anterior cruciate ligament (ACL) reconstruction subjects
Primary Outcome
Max torque produced in newton meter per second during an isometric contraction
Interventions
- OTHER blood flow restriction
- OTHER physical therapy standard of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2022-04-18 |
| Est. Completion | 2023-01-30 |
| Phase | NA |
Why NCT05245864 stopped before completion
NCT05245864 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which blood flow restriction is the first listed.
NCT05245864 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05245864 about?
NCT05245864 is a clinical study titled "Blood Flow Restriction Training in ACL Surgery". This will be a randomized pilot study to determine the effectiveness of Personalized Blood Flow Restriction (PBFR) technique in conjunction with prescribed physical therapy (PT) in a cohort of anterior cruciate ligament (ACL) reconstruction subjects
What is the current status of trial NCT05245864?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2022-04-18. Estimated completion is 2023-01-30.
What interventions are being tested in trial NCT05245864?
The interventions under investigation include: blood flow restriction (OTHER), physical therapy standard of care (OTHER).
Who is sponsoring clinical trial NCT05245864?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05245864's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI